Clinical Trial Update: Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates the efficacy, safety, tolerability, and pharmacokinetics of NBI-827104 in pediatric subjects with epileptic encephalopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Electrical Status Epilepticus in Sleep
• Epileptic Encephalopathy

Drugs mentioned

• NBI-827104

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Epileptic Encephalopathy, Continuous Spike and Wave During Sleep | Phase 2 | Status: COMPLETED | Results posted: 2025-09-05